{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:09:43Z","timestamp":1789823383902,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004793","name":"Minist\u00e8re de l\u2019Education Nationale, de l\u2019Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28915-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:34:53Z","timestamp":1763667293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Key domains involved in the interaction and assembly of the HCMV terminase complex"],"prefix":"10.1038","volume":"15","author":[{"given":"C.","family":"Gourin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Couvreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ligat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"7","key":"28915_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","volume":"89","author":"CN Kotton","year":"2010","unstructured":"Kotton, C. N. et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 89 (7), 779\u2013795 (2010).","journal-title":"Transplantation 15 Avr"},{"key":"28915_CR2","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","volume":"40","author":"M Leruez-Ville","year":"2024","unstructured":"Leruez-Ville, M. et al. Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg. Health Eur. Mai. 40, 100892 (2024).","journal-title":"Lancet Reg. Health Eur. Mai"},{"issue":"4","key":"28915_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1051\/medsci\/2020063","volume":"36","author":"G Ligat","year":"2020","unstructured":"Ligat, G., Muller, C., Alain, S. & Hantz, S. Le complexe terminase, Une cible de Choix Dans Le traitement de l\u2019infection \u00e0 cytom\u00e9galovirus Humain. Med. Sci. (Paris) . 36 (4), 367\u2013375 (2020).","journal-title":"Med. Sci. (Paris) 1 Avr"},{"issue":"24","key":"28915_CR4","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41388-023-02709-3","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba, R. et al. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene 42 (24), 2031\u20132045 (2023).","journal-title":"Oncogene"},{"key":"28915_CR5","doi-asserted-by":"crossref","unstructured":"Guyon, J. et al. Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes. Cancer Gene Ther. 1\u201311. (2024).","DOI":"10.1038\/s41417-024-00767-7"},{"key":"28915_CR6","doi-asserted-by":"crossref","unstructured":"Gourin, C. et al. Challenges and advances in the management of HCMV infections. Virologie (Montrouge). 28(5), 309\u2013325 (2024).","DOI":"10.1684\/vir.2024.1063"},{"issue":"8","key":"28915_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1470-2045(25)00403-6","volume":"26","author":"MR Karagas","year":"2025","unstructured":"Karagas, M. R. et al. Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. Lancet Oncol.. 26 (8), 994\u2013995 (2025).","journal-title":"Lancet Oncol."},{"issue":"9","key":"28915_CR8","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable, R. R. & Humar, A. Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American society of transplantation infectious diseases community of practice. Clin. Transplant. 33 (9), e13512 (2019).","journal-title":"Clin. Transplant."},{"issue":"2","key":"28915_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/femsre\/fuy004","volume":"42","author":"G Ligat","year":"2018","unstructured":"Ligat, G., Cazal, R., Hantz, S. & Alain, S. The human cytomegalovirus terminase complex as an antiviral target: a close-up view. FEMS Microbiol. Rev.. 42 (2), 137\u2013145 (2018).","journal-title":"FEMS Microbiol. Rev."},{"key":"28915_CR10","doi-asserted-by":"crossref","unstructured":"Marty, F. M. et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N. Engl. J. Med. 377(25), 2433\u20132444 (2017).","DOI":"10.1056\/NEJMoa1706640"},{"issue":"3","key":"28915_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/AAC.01596-09","volume":"54","author":"P Lischka","year":"2010","unstructured":"Lischka, P. et al. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob. Agents Chemother. Mars. 54 (3), 1290\u20131297 (2010).","journal-title":"Antimicrob. Agents Chemother. Mars"},{"issue":"8","key":"28915_CR12","first-page":"2253","volume":"75","author":"S Alain","year":"2020","unstructured":"Alain, S. et al. Letermovir breakthroughs during the French named patient programme: interest of monitoring blood concentration in clinical practice. J. Antimicrob. Chemother. 1 ao\u00fbt. 75 (8), 2253\u20132257 (2020).","journal-title":"J. Antimicrob. Chemother. 1 ao\u00fbt"},{"issue":"10","key":"28915_CR13","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1128\/AAC.01623-15","volume":"59","author":"S Chou","year":"2015","unstructured":"Chou, S. Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance. Antimicrob. Agents Chemother. oct. 59 (10), 6588\u20136593 (2015).","journal-title":"Antimicrob. Agents Chemother. oct."},{"issue":"29","key":"28915_CR14","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/bi0600796","volume":"45","author":"C Thoma","year":"2006","unstructured":"Thoma, C. et al. Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Biochem.. 45 (29), 8855\u20138863 (2006).","journal-title":"Biochem. 1 Juill"},{"key":"28915_CR15","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.1038\/s41598-017-09469-7","volume":"7","author":"G Ligat","year":"2017","unstructured":"Ligat, G. et al. Identification of a short sequence in the HCMV terminase pUL56 essential for interaction with pUL89 subunit. Sci. Rep.. 7, 8796 (2017).","journal-title":"Sci. Rep."},{"issue":"9","key":"28915_CR16","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1074\/jbc.M108984200","volume":"277","author":"JS Hwang","year":"2002","unstructured":"Hwang, J. S. & Bogner, E. ATPase activity of the terminase subunit pUL56 of human Cytomegalovirus*. J. Biol. Chem.. 277 (9), 6943\u20136948 (2002).","journal-title":"J. Biol. Chem."},{"issue":"37","key":"28915_CR17","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1073\/pnas.1007144107","volume":"107","author":"M Nadal","year":"2010","unstructured":"Nadal, M. et al. Structure and Inhibition of herpesvirus DNA packaging terminase nuclease domain. Proc. Natl. Acad. Sci. U S. 107 (37), 16078\u201316083 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S"},{"issue":"7","key":"28915_CR18","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/nar\/30.7.1695","volume":"30","author":"H Scheffczik","year":"2002","unstructured":"Scheffczik, H., Savva, C. G. W., Holzenburg, A., Kolesnikova, L. & Bogner, E. The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucleic Acids Res.. 30 (7), 1695\u20131703 (2002).","journal-title":"Nucleic Acids Res."},{"issue":"8016","key":"28915_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nat. Juin. 630 (8016), 493\u2013500 (2024).","journal-title":"Nat. Juin"},{"issue":"5","key":"28915_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13238-020-00710-0","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Architecture of the herpesvirus genome-packaging complex and implications for DNA translocation. Protein Cell. Mai. 11 (5), 339\u2013351 (2020).","journal-title":"Protein Cell. Mai"},{"key":"28915_CR21","doi-asserted-by":"crossref","unstructured":"Couvreux, A. et al. Insight into the structure of the pUL89 C-terminal domain of the human cytomegalovirus terminase complex. Proteins Struct. Funct. Bioinf. 78(6), 1520\u201330. (2010).","DOI":"10.1002\/prot.22669"},{"issue":"5","key":"28915_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/nar\/gkg229","volume":"31","author":"B Scholz","year":"2003","unstructured":"Scholz, B., Rechter, S., Drach, J. C., Townsend, L. B. & Bogner, E. Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucleic Acids Res.. 31 (5), 1426\u20131433 (2003).","journal-title":"Nucleic Acids Res."},{"key":"28915_CR23","doi-asserted-by":"crossref","unstructured":"Ligat, G., Couvreux, A., Cazal, R., Alain, S. & Hantz, S. nov. Highlighting of a LAGLIDADG and a zing finger motifs located in the pUL56 sequence crucial for HCMV Replication. Viruses. 12, 1093 (2019).","DOI":"10.3390\/v11121093"},{"issue":"2","key":"28915_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/135965350701200209","volume":"12","author":"G Champier","year":"2007","unstructured":"Champier, G. et al. New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. Antivir Ther. 12 (2), 217\u2013232 (2007).","journal-title":"Antivir Ther."},{"issue":"12","key":"28915_CR25","doi-asserted-by":"publisher","first-page":"e1008175","DOI":"10.1371\/journal.ppat.1008175","volume":"15","author":"J Thei\u00df","year":"2019","unstructured":"Thei\u00df, J., Sung, M. W., Holzenburg, A. & Bogner, E. Full-length human cytomegalovirus terminase pUL89 adopts a two-domain structure specific for DNA packaging. PLoS Pathog. 15 (12), e1008175 (2019).","journal-title":"PLoS Pathog."},{"issue":"13","key":"28915_CR26","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1128\/JVI.00384-16","volume":"90","author":"EM Borst","year":"2016","unstructured":"Borst, E. M. et al. The essential human cytomegalovirus proteins pUL77 and pUL93 are structural components necessary for viral genome encapsidation. J. Virol.. 90 (13), 5860\u20135875 (2016).","journal-title":"J. Virol."},{"issue":"5","key":"28915_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1128\/JVI.01967-07","volume":"82","author":"EM Borst","year":"2008","unstructured":"Borst, E. M., Wagner, K., Binz, A., Sodeik, B. & Messerle, M. The essential human cytomegalovirus gene UL52 is required for Cleavage-Packaging of the viral genome. J. Virol.. 82 (5), 2065\u20132078 (2008).","journal-title":"J. Virol."},{"issue":"23","key":"28915_CR28","doi-asserted-by":"publisher","first-page":"14660","DOI":"10.1128\/JVI.79.23.14660-14667.2005","volume":"79","author":"A Dittmer","year":"2005","unstructured":"Dittmer, A., Drach, J. C., Townsend, L. B., Fischer, A. & Bogner, E. Interaction of the putative human cytomegalovirus portal protein pUL104 with the large terminase subunit pUL56 and its Inhibition by benzimidazole-D-ribonucleosides. J. Virol.. 79 (23), 14660\u201314667 (2005).","journal-title":"J. Virol."},{"key":"28915_CR29","doi-asserted-by":"crossref","unstructured":"Harmening, S. et al. Interaction of human cytomegalovirus pUL52 with major components of the viral DNA encapsidation network underlines its essential role in genome cleavage-packaging. J. Virol.. e02201\u2013e02224 (2025).","DOI":"10.1128\/jvi.02201-24"},{"key":"28915_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1743-422X-9-315","volume":"9","author":"JB Wang","year":"2012","unstructured":"Wang, J. B., Zhu, Y., McVoy, M. A. & Parris, D. S. Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits. Virol. J.. 9, 315 (2012).","journal-title":"Virol. J. 21 d\u00e9c"},{"key":"28915_CR31","doi-asserted-by":"crossref","unstructured":"Neuber, S., Wagner, K., Messerle, M. & Borst, E. M. The C-terminal part of the human cytomegalovirus terminase subunit pUL51 is central for terminase complex assembly. J. Gen. Virol. 99(1), 119\u2013134 (2018).","DOI":"10.1099\/jgv.0.000984"},{"issue":"12","key":"28915_CR32","doi-asserted-by":"publisher","first-page":"e02384","DOI":"10.1128\/JVI.02384-16","volume":"91","author":"S Neuber","year":"2017","unstructured":"Neuber, S. et al. Mutual interplay between the human cytomegalovirus terminase subunits pUL51, pUL56, and pUL89 promotes terminase complex formation. J. Virol.. 91 (12), e02384\u2013e02316 (2017).","journal-title":"J. Virol."},{"issue":"8","key":"28915_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.embor.7400480","volume":"6","author":"K Michelsen","year":"2005","unstructured":"Michelsen, K., Yuan, H. & Schwappach, B. Hide and run. EMBO Rep.. 6 (8), 717\u2013722 (2005).","journal-title":"EMBO Rep."},{"issue":"5","key":"28915_CR34","doi-asserted-by":"publisher","first-page":"107277","DOI":"10.1016\/j.jbc.2024.107277","volume":"300","author":"S Ando","year":"2024","unstructured":"Ando, S. et al. The luciferase-based in vivo protein\u2013protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction. J. Biol. Chem.. 300 (5), 107277 (2024).","journal-title":"J. Biol. Chem."},{"key":"28915_CR35","doi-asserted-by":"publisher","first-page":"199200","DOI":"10.1016\/j.virusres.2023.199200","volume":"335","author":"M Sch\u00fctz","year":"2023","unstructured":"Sch\u00fctz, M. et al. Cytomegalovirus Cyclin-dependent kinase ortholog vCDK\/pUL97 undergoes regulatory interaction with human Cyclin H and CDK7 to codetermine viral replication efficiency. Virus Res. 335, 199200 (2023).","journal-title":"Virus Res."},{"key":"28915_CR36","doi-asserted-by":"publisher","first-page":"105673","DOI":"10.1016\/j.antiviral.2023.105673","volume":"217","author":"C Muller","year":"2023","unstructured":"Muller, C., Alain, S. & Hantz, S. Identification of a leucine-zipper motif in pUL51 essential for HCMV replication and potential target for antiviral development. Antiviral Res.. 217, 105673 (2023).","journal-title":"Antiviral Res."},{"issue":"9","key":"28915_CR37","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/ph15091040","volume":"15","author":"S Alkhashrom","year":"2022","unstructured":"Alkhashrom, S. et al. A peptide inhibitor of the human cytomegalovirus core nuclear egress complex. Pharmaceuticals. 15 (9), 1040 (2022).","journal-title":"Pharmaceuticals"},{"key":"28915_CR38","doi-asserted-by":"publisher","first-page":"10334","DOI":"10.1038\/s41598-025-94809-1","volume":"15","author":"LM Kmetsch","year":"2025","unstructured":"Kmetsch, L. M., Tietze, H. & Bogner, E. Identification of a binding pocket of letermovir in the terminase subunit pUL56 of human cytomegalovirus. Sci. Rep.. 15, 10334 (2025).","journal-title":"Sci. Rep."},{"key":"28915_CR39","doi-asserted-by":"publisher","first-page":"130110","DOI":"10.1016\/j.bmcl.2025.130110","volume":"119","author":"H Xu","year":"2025","unstructured":"Xu, H., Li, B., Tang, K., Yang, J. & Zhan, P. Nucleoside antiviral agents with atypical structures and new targets. Bioorg. Med. Chem. Lett.. 119, 130110 (2025).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"28915_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.coviro.2011.10.024","volume":"1","author":"DM Coen","year":"2011","unstructured":"Coen, D. M. & Whitley, R. J. Antiviral drugs and antiviral drug resistance. Curr. Opin. Virol.. 1 (6), 545\u2013547 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"28915_CR41","doi-asserted-by":"crossref","unstructured":"Yu, D. et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics. 16(2), 158 (2024).","DOI":"10.3390\/pharmaceutics16020158"},{"key":"28915_CR42","doi-asserted-by":"crossref","unstructured":"Tillmanns, J. et al. Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target. Cells. 14(8), 1162 (2023).","DOI":"10.3390\/cells12081162"},{"key":"28915_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1321116","author":"C Gourin","year":"2023","unstructured":"Gourin, C., Alain, S. & Hantz, S. Anti-CMV therapy, what next? A systematic review. Front. Microbiol. [Internet]. https:\/\/doi.org\/10.3389\/fmicb.2023.1321116 (2023). https:\/\/www.frontiersin.org\/articles\/[cit\u00e9 22 nov 2023];14. Disponible sur.","journal-title":"Front. Microbiol. [Internet]"},{"key":"28915_CR44","doi-asserted-by":"publisher","first-page":"106259","DOI":"10.1016\/j.antiviral.2025.106259","volume":"242","author":"S Mafi","year":"2025","unstructured":"Mafi, S., Poyet, J. L., Alain, S., Ligat, G. & Hantz, S. First evidence of efficacy of peptides targeting the pUL56-pUL89 interaction domain of the human cytomegalovirus terminase complex. Antiviral Res. 242, 106259 (2025).","journal-title":"Antiviral Res."},{"issue":"10","key":"28915_CR45","doi-asserted-by":"publisher","first-page":"8320","DOI":"10.1128\/JVI.73.10.8320-8329.1999","volume":"73","author":"EM Borst","year":"1999","unstructured":"Borst, E. M., Hahn, G., Koszinowski, U. H. & Messerle, M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73 (10), 8320\u20138329 (1999).","journal-title":"J. Virol."},{"issue":"1","key":"28915_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.antiviral.2013.02.002","volume":"98","author":"S Hantz","year":"2013","unstructured":"Hantz, S. et al. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model. Antiviral Res.. 98 (1), 130\u2013134 (2013).","journal-title":"Antiviral Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28915-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:03:10Z","timestamp":1777395790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28915-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28915-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44943"}}